A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.


Updates from The Motley Fool

Latest updates on Cytori Therapeutics from Fool.com.


Stock Performance

CYTX vs. S&P 500 | 2 Year Performance
View Interactive CYTX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cytori Therapeutics.
Current Price: $2.01
Prev Close: $2.01
Open: $2.01
Bid: $1.99
Ask: $2.00
Day's Range: $1.95 - $2.08
52wk Range: $1.91 - $7.94
Volume: 78,076
Avg Vol 147,322
Market Cap: $318.56M
P/E (ttm): 0.08
EPS (ttm): $26.40
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cytori Therapeutics.
CAPS Rating 1 out of 5
 
180 Outperform
35 Underperform
CAPS All Stars
 
14 Outperform
20 Underperform

How do you think Cytori Therapeutics will perform against the market?



You pick for Cytori Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Marc H. Hedrick, CEO

61% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Cytori Therapeutics.

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers